WALSH COLIN
SEC insider (Form 3/4/5 filer). CIK 0001866174. Director at Attovia Therapeutics, Inc. (ATTO). 27 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in NEW YORK, NY.
Companies WALSH COLIN has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO): Director
WALSH COLIN
CIK: 0001866174
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Attovia Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionIndirect2M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionIndirect478.5K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseIndirect500K shares at avg. $17.00$8.5M - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect447 shares at avg. $21.87$10K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect1.6K shares at avg. $22.06$34K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect3.4K shares at avg. $22.02$75K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect200 shares at avg. $22.05$4K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect480 shares at avg. $21.55$10K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect100 shares at avg. $22.11$2K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect200 shares at avg. $22.10$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 1,957,134 | - | $0 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 478,498 | - | $0 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 500,000 | $17.00 | $8,500,000 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 447 | $21.87 | $9,776 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 1,556 | $22.06 | $34,325 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 3,402 | $22.02 | $74,912 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 200 | $22.05 | $4,410 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 480 | $21.55 | $10,344 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 100 | $22.11 | $2,211 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 200 | $22.10 | $4,420 | Indirect |
1-10 of 27 transactions